InsidersTradesSigma
Follow the ネクセラファーマ(株) stock price and the full directors' dealings record of the company, a listed equity based in Japan. Shares are quoted on JP JP, under the supervision of EDINET (Japan FSA). The latest transaction was filed on 22 May 2026 (Holding update). Among the most active insiders: Mizuho Securities Co., Ltd.. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
Nexela Pharma Co., Ltd. is a Japanese company listed on the Tokyo Stock Exchange, specializing in the pharmaceutical sector. It focuses on the development of innovative treatments and health solutions.